Sydney, Australia (PRWEB) March 20, 2013
Applied Physiology® Pty Ltd, a leading innovator of clinical decision support technology, today announced that the U.S. Patent and Trademark Office has awarded a key patent for its unique Navigator™ technology covering its computerized methods of providing guidance and control of the circulation.
“The award of this broad suit of claims confirms our leading position in the marketplace for advanced cardiovascular decision support,” said Dr Steve Gourlay, MD PhD, Chairman and Chief Executive Officer of Applied Physiology Ltd. “Applied Physiology’s FDA and CE Mark-approved Navigator ™ has applications in a broad range of critical care situations including the intensive care unit, operating theatre and during dialysis.”
The potential health and cost benefits of decision support technology such as Navigator™ were recently highlighted in a systematic review of “Goal Directed Therapy” (Cecconi et al. Critical Care 2013, 17:209). This paper reported a reduction in complications across all subgroups studied and a reduction in mortality in sicker patients.
About Applied Physiology Pty Ltd
Applied Physiology is global clinical decision support systems company with operations in Australia, the UK and Europe. It develops and commercializes clinical decision support systems for the critical care market. Its leading product, Navigator™, is a guidance system for the circulation and is currently available as a touch screen monitor connectable to bedside multiparameter and cardiac output monitors.
Applied Physiology can be contacted at http://www.applied-physiology.com or +61 2 9209 4191.